Francesco Del Giudice | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Vesical imaging-reporting and data system (VI-RADS) for assessment of response to systemic therapy for bladder cancer: preliminary report	ABDOMINAL RADIOLOGY	2021
Three vs. four cycles of neoadjuvant chemotherapy for localized muscle invasive bladder cancer undergoing radical cystectomy: a retrospective multi-institutional analysis	FRONTIERS IN ONCOLOGY	2021
Influence of operative time and blood loss on surgical margins and functional outcomes for laparoscopic versus robotic-assisted radical prostatectomy: a prospective analysis	CENTRAL EUROPEAN JOURNAL OF UROLOGY	2021
Does Exist a Differential Impact of Degarelix Versus LHRH Agonists on Cardiovascular Safety? Evidences From Randomized and Real-World Studies	FRONTIERS IN ENDOCRINOLOGY	2021
Prostate cancer radiogenomics—from imaging to molecular characterization	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2021
Is there enough evidence available nowadays to suggest a paradigmatic shift in treatment of MIBC with perioperative systemic therapy administration?	MINERVA UROLOGY AND NEPHROLOGY	2021
The impact of sars-cov-2 pandemic on time to primary, secondary resection and adjuvant intravesical therapy in patients with high-risk non-muscle invasive bladder cancer: A retrospective multi-institutional cohort analysis	CANCERS	2021
The impact of diagnostic ureteroscopy prior to radical nephroureterectomy on oncological outcomes in patients with upper tract urothelial carcinoma: A comprehensive systematic review and meta-analysis	JOURNAL OF CLINICAL MEDICINE	2021
Evaluation of the reporting quality of clinical practice guidelines on prostate cancer using the RIGHT checklist	ANNALS OF TRANSLATIONAL MEDICINE	2021
Preserving ejaculatory function in young patients with lower urinary tract symptoms: medium- to long-term follow-up of prostatic urethral lift at a single center	THERAPEUTIC ADVANCES IN UROLOGY	2021
A risk-group classification model in patients with bladder cancer under neoadjuvant cisplatin-based combination chemotherapy	FUTURE ONCOLOGY	2021
Neutrophil percentage-to-albumin ratio predicts mortality in bladder cancer patients treated with neoadjuvant chemotherapy followed by radical cystectomy	FUTURE SCIENCE OA	2021
Increased Body Mass Index Is a Risk Factor for Poor Clinical Outcomes after Radical Prostatectomy in Men with International Society of Urological Pathology Grade Group 1 Prostate Cancer Diagnosed with Systematic Biopsies	UROLOGIA INTERNATIONALIS	2021
Does semen analysis testing reveal disparities?	NATURE REVIEWS. UROLOGY	2021
Male fertility as a marker for health	REPRODUCTIVE BIOMEDICINE ONLINE	2021
The association between 2,4-D and serum testosterone levels: NHANES 2013–2014	JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION	2021
Systemic combining inflammatory score (SCIS): A new score for prediction of oncologic outcomes in patients with high-risk non-muscle-invasive urothelial bladder cancer	TRANSLATIONAL ANDROLOGY AND UROLOGY	2021
Assessment of psim (Prostatic systemic inflammatory markers) score in predicting pathologic features at robotic radical prostatectomy in patients with low-risk prostate cancer who met the inclusion criteria for active surveillance	DIAGNOSTICS	2021
Artificial intelligence and machine learning in prostate cancer patient management—current trends and future perspectives	DIAGNOSTICS	2021
From Myo-inositol to D-chiro-inositol molecular pathways	EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES	2021

ERC

LS4_12

Interessi di ricerca

Genito Urinary Oncology
Minimally Invasive Robotic-Assisted Urologic Surgery
Urothelial Solid Neoplasms
Non-Muscle Invasive Bladder Cancer
Muscle-Invasive Bladder Cancer
Upper Tract Urothelial Carcinomas

Progetti di Ricerca

Magnetic Resonance Imaging-Targeted Biopsy for Primary Detection of Prostate Cancer: Magnetic Resonance Imaging (MRI) In-Bore versus MRI-Trans-rectal ultrasound (TRUS) Fusion Technique
Co-expression of Programmed Death Ligand 1 (PD-L1) and markers of Epithelial-Mesenchymal Transition (EMT) on Circulating Tumor Cells (CTCs): a possible immune escape mechanism in urothelial carcinomas of the urinary bladder.